Search company, investor...
AffyXell Therapeutics company logo

AffyXell Therapeutics

affyxell.com

Founded Year

2020

Stage

Corporate Minority - II | Alive

Total Raised

$7.3M

About AffyXell Therapeutics

AffyXell Therapeutics provides biotechnology services. The company develops mesenchymal stem cells (MSCs) which are promising agents for the treatment of autoimmune and inflammatory diseases. AffyXell Therapeutics was founded in 2020 and is based in Gyeongsangnam-do, South Korea.

Headquarters Location

404, Gimhae Biomedical Industry Promotion Agency Techno Town, 80-59, Golden Route-ro, Juchon-myeon, Gimhae-si, 205-room B-205, Gwanggyo Umi Newv Knowledge Industry Center

Gyeongsangnam-do,

South Korea

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo
You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo

Latest AffyXell Therapeutics News

UK: Avacta shareholding in AffyXell increases and Diagnostic’s division acquires Coris

Jun 6, 2023

UK-based Avacta Group, a life sciences company developing targeted oncology drugs and powerful diagnostics, has announced that a second milestone equity payment has been triggered resulting in an increase in Avacta’s shareholding in AffyXell Therapeutics. Avacta’s Diagnostics division also recently completed the acquisition of Coris Bioconcept in Belgium as part of its growth strategy. South Korea […]

AffyXell Therapeutics Frequently Asked Questions (FAQ)

  • When was AffyXell Therapeutics founded?

    AffyXell Therapeutics was founded in 2020.

  • Where is AffyXell Therapeutics's headquarters?

    AffyXell Therapeutics's headquarters is located at 404, Gimhae Biomedical Industry Promotion Agency Techno Town, 80-59, Golden Route-ro, Juchon-myeon, Gimhae-si, , Gyeongsangnam-do.

  • What is AffyXell Therapeutics's latest funding round?

    AffyXell Therapeutics's latest funding round is Corporate Minority - II.

  • How much did AffyXell Therapeutics raise?

    AffyXell Therapeutics raised a total of $7.3M.

  • Who are the investors of AffyXell Therapeutics?

    Investors of AffyXell Therapeutics include Avacta Group, Samsung Ventures, Stonebridge Ventures, Smilegate Investment, Gyeongnam Venture Investment and 6 more.

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.